MDA5-related juvenile dermatomyositis and interstitial lung disease: Transitioning from rapid progression to a quiescent state in three pediatric cases from South Africa, along with a literature review. - Takeaways - MDSpire

MDA5-related juvenile dermatomyositis and interstitial lung disease: Transitioning from rapid progression to a quiescent state in three pediatric cases from South Africa, along with a literature review.

  • By

  • Maurane Lepage

  • Gabriella Pereira

  • Shehnaaz Akhalwaya

  • Taryn Gray

  • Marco Zampoli

  • Mignon McCulloch

  • Peter Nourse

  • Ashton Coetzee

  • Claire Procter

  • Khanyisile Hlongwa

  • Tanyia Pillay

  • Kate Webb

  • April 22, 2026

  • 0 min

Share

  • 1

    Juvenile dermatomyositis (JDM) is a rare autoimmune disease in children, characterized by muscle weakness and skin manifestations.

  • 2

    Anti-MDA5 autoantibodies in JDM patients are associated with a higher risk of interstitial lung disease (ILD) and rapid progression.

  • 3

    The prevalence of anti-MDA5 in JDM varies globally, with significant differences in ILD development rates among different populations.

  • 4

    This article presents three cases of African children with anti-MDA5-associated JDM and ILD, highlighting their clinical features and treatment responses.

  • 5

    Therapeutic strategies for severe cases of anti-MDA5 JDM include immunosuppressants, rituximab, and therapeutic plasma exchange.

Original Source(s)

MDA5-related juvenile dermatomyositis and interstitial lung disease: Transitioning from rapid progression to a quiescent state in three pediatric cases from South Africa, along with a literature review.

  • by Maurane Lepage, Gabriella Pereira, Shehnaaz Akhalwaya, Taryn Gray, Marco Zampoli, Mignon McCulloch, Peter Nourse, Ashton Coetzee, Claire Procter, Khanyisile Hlongwa, Tanyia Pillay, Kate Webb

  • April 22, 2026

Related Content

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

Semaglutide Use Linked to Erythromelalgia Remission

Case details diagnostic workup and rapid symptom resolution following GLP-1 receptor agonist initiation.

Clinical Characteristics, Autoantibody Profiles, and Therapeutic Outcomes of Juvenile Systemic Sclerosis: An 11-Year Single-Center Experience from China